Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Apr;76(2):130-5.
doi: 10.1016/0962-8479(95)90555-3.

Serum soluble interleukin-2 receptor: a useful indicator of the clinical course in pulmonary tuberculosis

M J Avilés Inglés  1 , C Contessotto, J Ontañón Rodriguez, A García Alonso, M Muro Amador, M Canteras Jordana, F Sánchez Gascón, R Alvarez López
Affiliations

Serum soluble interleukin-2 receptor: a useful indicator of the clinical course in pulmonary tuberculosis

M J Avilés Inglés et al. Tuber Lung Dis. 1995 Apr.

Abstract

Setting: In tuberculosis both host protection and most pathogenic mechanisms depend on T lymphocytes. After activation by mycobacterial antigens, T cells both secrete interleukin-2 (IL-2) and express a high affinity receptor for this molecule (IL-2R) on their own surface. A soluble fraction of IL-2 receptor (sIL-2R), released from cell membrane, is detectable in serum and its concentration is known to be elevated in tuberculosis.

Objective: To ascertain the role of sIL-2R as an indicator of clinical evolution and response to antituberculosis treatment.

Design: A prospective study, in which we have measured serum sIL-2R in 52 patients (42 with active and 10 with inactive pulmonary tuberculosis) and in 36 healthy controls. In 20 patients, serum sIL-2R levels were measured serially throughout the treatment. Levels of sIL-2R were correlated to clinical and radiological parameters.

Results: Serum sIL-2R was significantly increased in patients with tuberculosis as compared to healthy subjects. Both the radiological findings and the clinical state of patients showed a good correlation with sIL-2R. All patients with normal values of sIL-2R 6 months after starting therapy had a favourable clinical evolution.

Conclusion: Serum sIL-2R is a useful marker of the clinical state and evolution of patients with pulmonary tuberculosis. The detection of permanently high values beyond 3-6 months of treatment suggests that additional drugs or prolonged administration would be advisable in order to ensure full recovery.

PubMed Disclaimer

Substances